NCT00476723
HBV-specific T-cell Immunity in Individuals With HIV/HBV Co-infection No drug interventions Not Available Not Available completed NCT03985085
Sexual and Reproductive Health (Including PrEP and HBV) for Female Sex Workers in Côte d'Ivoire No drug interventions health_services_research Not Available unknown_status NCT01953458
Therapeutic Option for Hepatitis B and C: a French Cohort No drug interventions Not Available Not Available active_not_recruiting NCT05683548
Replicor Compassionate Access Program Not Available Not Available available NCT06403657
DEcentralize Testing, Education, and Linkage to Care by Using Electronic Best Practice Advisory for Hepatitis B (DETECT-B) No drug interventions health_services_research Not Available not_yet_recruiting NCT04690972
"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases". No drug interventions Not Available Not Available not_yet_recruiting NCT03032536
Study of the Relative Oral Bioavailability of AL-3778 Tablets and Drug Interaction With Entecavir or Tenofovir Disoproxil Fumarate in Healthy Volunteers treatment 1 terminated NCT03854630
Hepatitis B Virus Vaccination in HIV-positive Patients and Individuals at High Risk for HIV Infection prevention 4 unknown_status NCT01199601
Blood-borne Infection Screening in an Afghan Antenatal Population No drug interventions other Not Available completed NCT06497504
Study of Bepirovirsen in Participants Living With Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection (B-Focus) No drug interventions treatment 2 recruiting NCT00001971
Evaluation of Patients With Liver Disease No drug interventions Not Available Not Available recruiting NCT02766933
Cameroon Baptist Convention Health Board Chronic Hepatitis B Cohort Study No drug interventions Not Available Not Available active_not_recruiting NCT03620474
Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver Cirrhosis treatment 1 / 2 completed NCT06618196
Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of Age No drug interventions prevention 2 not_yet_recruiting NCT00004850
Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection No drug interventions Not Available Not Available completed NCT01350648
Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection No drug interventions Not Available Not Available completed NCT06623071
Accupower ® HBV Performance Evaluation Quant Kit Bioneer Existation FA 96/384 No drug interventions Not Available Not Available not_yet_recruiting NCT05064553
ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk No drug interventions Not Available Not Available recruiting NCT04954859
Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants (B-Sure) No drug interventions treatment 2 recruiting NCT05868005
Delivering a Multi-disease Screening Tool to Migrant Populations No drug interventions screening Not Available recruiting NCT06586983
Decentralization of Hepatitis B Care in Sub-Saharan Africa: a Pilot Program in Ethiopia Not Available Not Available recruiting NCT02003703
Comparative Efficacy of an Intensified Re-vaccination Scheme for Hepatitis B Virus Infection Among Patients Infected With HIV . prevention 3 completed NCT02445703
Comparison of Immunization Schedules of Inactivated Hepatitis A Vaccine and Combined Hepatitis A and Hepatitis B Vaccine prevention 4 completed NCT04326803
Hepatitis B en Haitian Immigrants in Chile: Molecular Characterization and Determination of Vaccine Response prevention 4 unknown_status NCT01139203
Prophylaxis of Hepatitis B Virus Recurrence After Liver Transplantation prevention Not Available unknown_status NCT03219203
Immunologic Response of Hepatitis B Vaccine prevention 4 unknown_status NCT00051090
Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients With Both HBV and HIV treatment Not Available withdrawn NCT00106964
Comparison of Three Hepatitis B Vaccination Regimens in HIV-Positive Youth prevention 4 completed NCT00356564
Persistence of the Immune Response to Hepatitis B in 7-9 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib prevention 4 completed NCT01772121
Observational Study on Prevalence of Host and Viral Genotypes in Chronic Hepatitis B and Hepatitis C Patients in India No drug interventions Not Available Not Available completed NCT00496002
Efficacy and Safety of Clevudine Compared With Adefovir in Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B Virus treatment 3 terminated NCT02981602
Safety, Tolerability, Pharmacokinetics and Antiviral Activity of IONIS-HBVRx in Treatment-Naïve Patients With Chronic HBV Infection treatment 2 completed NCT00619502
Study of Immunogenicity and Safety of a Booster Dose of DTaP-IPV-HB-PRP~T Combined Vaccine in Healthy Turkish Infants No drug interventions prevention 3 completed NCT01248884
Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744) prevention 2 completed NCT00197184
Long Term Follow-up Study at Years 2, 3, 4 and 5 Where 2 Dosing Schedules of the Combined Hepatitis A and B Vaccine Were Compared prevention 3 completed NCT05988879
Functional Cure of Hepatitis B in HIV/HBV Co-infected Patients Not Available Not Available recruiting NCT06368479
Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Site Settings No drug interventions screening Not Available active_not_recruiting NCT00698087
Comparison of Safety, Immuno- and Reactogenicity of MPL-Adjuvanted Recombinant Hepatitis B Vaccine to That of Engerix™-B prevention 3 completed NCT01470287
Immunogenicity, Safety and Tolerability of a Fully Liquid Pentavalent (DTwP-Hib-Hep B) Vaccine in Infants 6-8 Weeks of Age No drug interventions prevention 3 completed NCT01715987
Tubular Function in Asian-American Patients Receiving TDF or ETV for HBV Treatment Not Available Not Available terminated NCT05127187
Estimation of the Prevalence of HIV, Hepatitis C and Hepatitis B Infection Among Detainees in the Nîmes Administrative Detention Center No drug interventions Not Available Not Available completed NCT03977987
Maternal Antiviral Treatment and Infants Immunoprophylaxis in the Prevention of Mother-to-child Transmission No drug interventions Not Available Not Available completed NCT00534833
Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB-PRP~T Combined Vaccine or Tritanrix-HepB/Hib™ prevention 3 completed NCT00100633
Safety of and Immune Response to a Hepatitis B Virus Vaccine Given With a Booster (CpG7909 ODN) in HIV Infected and HIV Uninfected People treatment 1 / 2 completed NCT04525833
Liver Disease and Other Systemic Diseases No drug interventions Not Available Not Available unknown_status NCT02094833
DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed Infants prevention 3 completed NCT04294433
Immunogenicity of 2 Versus 3 Doses of Combined Hepatitis B Vaccines in 2-18 Months Old Children prevention 3 unknown_status NCT01970254
Widespread vs. Selective Screening for Hepatitis B Infection Prior to Chemotherapy No drug interventions Not Available Not Available completed NCT04029454
Neovac 2 Burkina Faso: Impact of the Integration of Hepatitis B Birth Dose Vaccine Into the Infant Immunization Schedule prevention Not Available completed NCT00697554
Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Pre-liver Transplant Patients 18 Years of Age No drug interventions prevention 3 completed NCT05472051
Health and Migration Trajectories of Housekeepers in Bamako No drug interventions Not Available Not Available completed NCT02817451
DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and Uninfected Infants prevention 3 completed NCT05791851
Heplisav-B Revaccination for Hepatitis B Vaccine Nonresponders No drug interventions Not Available Not Available completed NCT00697853
Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine (2 Doses), and of Engerix™-B (3 Doses) in Healthy Adults No drug interventions prevention 2 completed NCT01259453
Hepatitis B Vaccination Through Syringe Exchange Programs: A Randomized, Controlled Trial of Vaccination Schedules No drug interventions prevention 4 completed NCT04540653
Immunogenicity of the Hepatitis B Vaccine No drug interventions prevention 4 unknown_status NCT03123653
To Study the Efficacy of PEG-IFN Alpha in HBeAg Negative Chronic Hepatitis B Patients After Stopping Nucleotide Analogue Therapy. No drug interventions treatment Not Available unknown_status NCT01988753
Non-invasive Biomarkers of Fibrosis in Pediatric Liver Diseases No drug interventions Not Available Not Available completed NCT01126853
Combination Hepatitis A and B Vaccine to Induce Immunity in Non-responders prevention 4 withdrawn NCT04588077
Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis prevention 4 recruiting NCT00230477
Hepsera Versus Hepsera Plus Lamivudine for Treatment of Chronic Hepatitis B in Patients With Normal ALT treatment 4 completed NCT00051077
Treatment of Hepatitis in Patients Who Are Triple-Infected With HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV) treatment 2 withdrawn NCT00316147
Immunogenicity & Safety of GSK's Combined DTPa-HBV-IPV/Hib Vaccine in Indian Infants at 2 Diff Vaccination Schedules prevention 3 completed NCT01821547
New Methods to Measure the Immune Response to Hepatitis B Vaccine basic_science 4 completed NCT02782247
Dynamic Liver Tests in Liver Disease No drug interventions Not Available Not Available completed NCT02331745
RCT Study on Granulocyte Colony-stimulating Factor(G-CSF) Treatment of Hepatic Failure treatment 4 unknown_status NCT03020745
A Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK3389404 in Chronic Hepatitis B (CHB) Subjects No drug interventions treatment 2 completed NCT02257645
Post-authorization Safety Study of Euforvac-Hib Vaccine for Active Primary Immunization in Infants From 6 Weeks No drug interventions Not Available Not Available unknown_status NCT03801798
A Study of GC1102(Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B Patients treatment 2 unknown_status NCT04059198
Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic Treatment Naive Subjects Infected With Hepatitis B Virus treatment 2 terminated NCT02012998
Study of the Immunogenicity and Safety of a Challenge Dose of HBVAXPRO in Healthy Children Vaccinated 10 Years Ago With 3 Doses of HEXAVAC or INFANRIX HEXA prevention 3 completed NCT02344498
Treatment of Hepatitis B in Resource-limited Settings - a Pilot Program in East Africa Not Available Not Available active_not_recruiting NCT00362505
Safety and Antiviral Activity of Clevudine in Patients Who Have Completed the L-FMAU-301 or L-FMAU-302 Trials treatment 3 terminated NCT04659005
Nurse-led Decision Counseling on Hepatocellular Carcinoma Screening No drug interventions screening Not Available completed NCT05692505
Multicenter Performance Study of QuadQuik Invitro Diagnostic Device No drug interventions Not Available Not Available not_yet_recruiting NCT02496897
Phase I Safety and Immunogenicity of FP-02.2 in Chronic Hepatitis B No drug interventions treatment 1 completed NCT01368497
Entecavir/Pegylated Interferon in Immune Tolerant Children With Chronic Hepatitis B Virus (HBV) Infection treatment 3 completed NCT03596697
A Study in Healthy Volunteers treatment 1 completed NCT05977283
HBsAg Declined Patients Follow-up Study No drug interventions Not Available Not Available recruiting NCT03680183
Clinical Pharmacokinetics of TKIs in Chinese Patients of Hepatitis B (HBV) Not Available Not Available unknown_status NCT00000583
Hepatitis B Vaccine Clinical Trial prevention 3 completed NCT00562783
A Phase II, Double-blinded, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Vitalliver in Patients With Decompensated Cirrhosis No drug interventions treatment 2 completed NCT00230061
Hepatitis B Vaccination in HIV-infected Persons prevention 4 completed NCT02687061
Chronic Hepatitis B and C Recall Northern Holland No drug interventions Not Available Not Available unknown_status NCT00114361
48 Weeks Combination Therapy for Patients With HBeAg-negative Chronic Hepatitis B Virus (HBV) Infection Not Available 3 completed NCT00313261
Safety and Efficacy Study of L-FMAU in Chronic HBV Patients of L-FMAU-201 Placebo Group treatment 2 terminated NCT00644761
PK Study of Tacrolimus and Cyclosporine When Co-Administered With Adefovir Dipivoxil in Post-Liver Transplant Patients treatment 2 completed NCT03870061
Evaluation of an Infant Immunization Encouragement Program in Nigeria No drug interventions prevention Not Available completed NCT00698061
Immunogenicity and Safety of an Adjuvanted HBV Vaccine Compared to Engerix™-B, in a Non-responder Population ≥ 15y No drug interventions prevention 3 completed NCT00172328
Antibody Response and Immune Memory 15-18 Years After HBV Vaccination prevention Not Available unknown_status NCT03640728
The Efficacy and Safety of Nucleos(t)Ide Analogues in the Treatment of HBV-related Acute-on-chronic Liver Failure Not Available Not Available recruiting NCT04056728
A Phase IV Study to Assess the Safety of EupentaTM Inj No drug interventions prevention 4 unknown_status NCT01182311
Duration of Long-term Immunity After Hepatitis B Virus Immunization No drug interventions Not Available Not Available completed NCT04363411
Reaching Out to the UNdiagnosed People Infected With Blood Borne Viral Infections No drug interventions prevention Not Available completed NCT04914611
Real World Assessment of People Living With Chronic Hepatitis B in Australia No drug interventions Not Available Not Available recruiting NCT00096811
Entecavir for Subjects With Chronic Hepatitis B Infection: An Early Access Program Not Available Not Available no_longer_available NCT00197171
Long Term F/U Studies at Y5&6 to Demonstrate the Equivalence of 2 Vaccination Schedules of Combined Hepatitis A & B Vaccine No drug interventions prevention 3 completed NCT02764671
Safety and Immunogenicity of Recombinant Hepatitis B Vaccines in the Neonates prevention 4 unknown_status NCT01727271
A Study to Compare Efficacy and Safety of Tenofovir Used Alone or in Combination With Pegylated Interferon Alpha-2b in Participants With Chronic Hepatitis B and Elevated Alanine Aminotransferase (MK-4031-384) treatment 4 withdrawn NCT00684671
Evaluation of Immune Memory to Twinrix or Comparator by Challenge Dose Administration 4 Years After Primary Vaccination prevention 4 completed NCT03568578
A Study in Reversing Hepatic Fibrosis or Cirrhosis Related to Hepatitis B Virus and Finding Biomarkers diagnostic Not Available unknown_status NCT01623778
Optimization of Antiviral Therapy of Chronic HBV Infection Not Available Not Available completed NCT03482388
Crowdsourcing to Promote HBV and HCV Testing in China No drug interventions screening Not Available completed NCT02417207
Entecavir Combined Short-term Intravenous Hepatitis B Immune Globulin (HBIG) to Prevent Hepatitis B Recurrence After Liver Transplantation treatment 4 unknown_status NCT00065507
Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients With Hepatic Decompensation treatment 3 completed NCT01441609
Expression of Th9 Cells and Poor/Non-responsiveness to Hepatitis B Vaccination No drug interventions Not Available Not Available unknown_status NCT03361956
An Efficacy, Safety, and Pharmacokinetics Study of JNJ-56136379 in Participants With Chronic Hepatitis B Virus Infection treatment 2 completed NCT00875485
Evaluation of Antibody Persistence & Immune Memory in Subjects Vaccinated During Adolescence With Twinrix™ No drug interventions prevention 4 completed NCT04386915
Study on the Tolerance and Pharmacokinetics of GST-HG141 Tablets No drug interventions treatment 1 unknown_status NCT00343915
Immuno & Safety Study of GSK Biologicals' Thio or Preservative Free Hepatitis B Vaccine in Subjects Aged 11-15 Yrs prevention 3 completed NCT05768737
Awareness of Osteoporosis in Patients With Hepatitis B Infection No drug interventions Not Available Not Available not_yet_recruiting NCT05446532
Coexistence HBsAg/HBcAC, Clinical Characterístics & Outcomes No drug interventions Not Available Not Available unknown_status NCT02849132
Effect of Entecavir Treatment on Regression and Disease Outcome in HBV-induced Liver Fibrosis and Cirrhosis Patients treatment 4 active_not_recruiting NCT02798952
A Study to Evaluate Persistence of Hepatitis B Antibodies, Immunogenicity and Safety of Engerix™-B Kinder Challenge Dose, in Adolescents Vaccinated With Four Doses of Infanrix™ Hexa During Infancy prevention 4 completed NCT00275652
A Comparison of the Drug Telbivudine (LdT) and Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis. treatment 3 completed NCT00603252
Study to Show That the Combined Hepatitis A and B Vaccine is Non-inferior to Monovalent Vaccines in Adults prevention 4 completed NCT00240500
Follow-up Study 16-20 Years After Primary Vaccination Against Hepatitis B of Newborns From HBeAg+ & HBsAg+ Mothers No drug interventions prevention 4 completed NCT04209400
Safety and Immunogenicity of Recombinant Hepatitis B Vaccine Sci-B-Vac® Compared to Engerix-B® prevention 3 completed NCT00376259
Study of Combination Therapy With LdT Plus Adefovir Versus Adefovir Alone treatment 3 terminated NCT05786859
The Efficacy and Safety of Rifaximin Treatment treatment 0 recruiting NCT00611559
Study of a New Formulation of DTPa-HBV-IPV/Hib Vaccine Administered as a Booster Dose to 18-23 Months Old Children prevention 4 completed NCT00127959
Virological and Clinical Anti-Hepatitis B Virus (HBV) Efficacy of Tenofovir and Emtricitabine in Patients With HIV/HBV co-Infection treatment 4 completed NCT04073459
Safety and Immunogenicity of Hexavalent Vaccine(DTwP-HepB-IPV-Hib) in Healthy Infants No drug interventions prevention 2 unknown_status NCT00147459
Immunogenicity of Booster Hepatitis B Vaccines in Children After Liver Transplantation No drug interventions diagnostic Not Available unknown_status NCT04947475
Project MATLINK: Development and Evaluation of a Screening, Brief Intervention, & Referral to Treatment (SBIRT) Program for Opioid Dependent Prisoners and Probationers Transitioning to the Community No drug interventions health_services_research Not Available active_not_recruiting NCT01341275
Adolescents' Response to Hepatitis B Vaccine Booster Dose prevention 4 unknown_status NCT00697970
Evaluation of Immunogenicity and Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine prevention 3 completed NCT04325542
Prevalence of HBV in Pregnant Women Attending Antenatal Care in Tanzania No drug interventions diagnostic Not Available completed NCT00432042
Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035) prevention 3 completed NCT02604199
A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Negative, Chronic Hepatitis B Virus (HBV) Infection treatment 2 terminated NCT01999699
A Study of the Immune Response to Heplisav in Healthy Older Adults No drug interventions basic_science 1 completed NCT01369199
Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis B treatment 3 terminated NCT00698906
Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 19-40 y No drug interventions prevention 2 completed NCT00493506
ProAlgaZyme Novel Algae Infusion: Applications in Immunodeficiency No drug interventions supportive_care Not Available completed NCT00704106
Hepatitis B Virus (HBV) Viral Suppression by Entecavir in Adefovir Partial Responders Not Available Not Available completed NCT00697749
Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Healthy Volunteers Positive for the HLA-DQ2 Genotype No drug interventions prevention 3 completed NCT00753649
Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants prevention 4 completed NCT00881036
Activation of Hepatitis B Virus (HBV) in Hepatitis B Surface Antigen (HBsAg) - Negative But Hepatitis B Core Antibody (Anti-HBc) - Positive Patients No drug interventions Not Available Not Available completed NCT00401336
Quantification of Liver Iron Overload and Steatosis Using Magnetic Resonance Imaging No drug interventions diagnostic Not Available completed NCT02040636
Study of Tetanus and Diphtheria Toxoids Adsorbed Combined With Component Pertussis Vaccine and Inactivated Poliomyelitis prevention 2 completed NCT02699736
EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV No drug interventions Not Available Not Available enrolling_by_invitation NCT04202536
Switching From Tenofovir Disoproxil Fumarate to Besifovir Dipivoxil Maleate treatment 4 unknown_status NCT04970836
The Immune Responses After Hepatitis B Revaccination Doses in a Young Cohort prevention Not Available recruiting NCT00186836
Efficacy Study of Combined Hepatitis A and Hepatitis B Vaccine to Protect Against Hepatitis B in Hemodialysis Patients prevention 4 completed NCT01861613
Seroprevalence of Hepatitis B and Immune Response to Hepatitis B Vaccination in Chinese College Students prevention 4 completed NCT03181113
Long-term Benefit in Chronic Hepatitis B Patients After Standard Peginterferon Alfa Therapy Not Available Not Available completed NCT03426618
A Real-World Observational Study for the Safety and Efficacy of Baraclude in Korean Pediatric Patients With Chronic Hepatitis B No drug interventions Not Available Not Available completed NCT03920618
Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLF treatment Not Available unknown_status NCT02324218
This Study Aims to Determine the Incidence, of Hepatitis B Diagnosis Among Diabetes Mellitus Patients of 0-80 Years of Age No drug interventions Not Available Not Available completed NCT05404919
Utilization of Hepatitis B Virus NAT+ Donors for Hepatitis B Vaccinated Lung Transplant Candidates treatment 2 withdrawn NCT00197119
Long-Term Follow-Up Studies at Year 6, 7, 8, 9, 10: 2 Formulations of Combined Hepatitis A/B Vaccine Compared in Subjects Aged 12-15 Years prevention 3 completed NCT00305019
Safety and Antiviral Activity of Clevudine in Patients Infected With Hepatitis B Virus treatment 2 terminated NCT00871741
Feasibility Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age. prevention 2 terminated NCT03534141
Mild Hypothermia and Acute Kidney Injury in Liver Transplantation No drug interventions prevention Not Available terminated NCT00158717
Observational Study of the Durability of Seroconversion Chronic HBV Patients Who Seroconverted in a Previous Gilead-Sponsored Study of ADV. Not Available Not Available completed NCT00228917
Safety Study of Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY Vaccines in Children prevention 3 completed NCT06084234
National Liver Cancer Screening Trial No drug interventions screening 4 recruiting NCT05304234
Liver Cancer Disparities in American Indian and Alaska Native Persons No drug interventions screening 2 recruiting NCT03604016
Study to Assess Efficacy of Besifovir and L-carnitine in Chronic Hepatitis B Patients With Nonalcoholic Fatty Liver treatment 4 unknown_status NCT00303316
Immunogenicity Study of Antibody Persistence and Booster Effect of PENTAXIM™ at 18 Months in Healthy Argentinean Infants prevention 3 completed NCT01896596
Hepatitis B Vaccination in Infants prevention 4 completed NCT01125696
Safety Study of a Tenofovir-containing Drug Regimen for the Prevention of Mother-to-child Transmission of HIV and HBV prevention 2 completed NCT00289796
Assess Feasibility of an Acellular Pertussis Vaccine (Pa) Given Soon After Birth, Followed by 3-dose Primary Vaccination With the DTPa-HBV-IPV/Hib Vaccine prevention 2 completed NCT00120796
Lamivudine and Therapeutic Vaccine Evaluation in Senegalese Patients With Chronic Hepatitis B Infection (ANRS 12100 HEPADAK-2) treatment 3 terminated NCT03396458
Hepatitis B Prevalence in the Turkish Population Living in Middle Limburg No drug interventions Not Available Not Available unknown_status NCT00169858
Long Term Immunogenicity Study of Engerix-B Vaccine in 10 Year Old Children and the Effect of Booster Injections prevention 4 completed NCT00362635
Compare the Efficacy and Safety of 48-week Treatment With Clevudine 30mg Versus Lamivudine 100mg for CHB Infection treatment 3 completed NCT00175435
Optimizing Hepatitis B Vaccine Response Through the Use of a Topical Immune Modulator prevention 1 / 2 completed NCT00146835
Post-marketing Safety Study of GSK Biological's Pediarix™ Vaccine Not Available Not Available completed NCT00044135
A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus. treatment 2 unknown_status NCT00320463
Compare Immunogenicity & Safety of 2 Formulations of GSK Biologicals' DTPa-HBV-IPV/Hib Vaccine Given in Healthy Infants prevention 3 completed NCT00352963
Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age). No drug interventions prevention 3 completed NCT00629486
Genetic Polymorphisms of Interleukin-1B and TNF-A and HBV-Related Hepatocellular Carcinoma No drug interventions basic_science Not Available completed NCT00670839
Trial Comparing Two Strategies of Vaccination Against Hepatitis B in HIV-infected Patients Non Responding to Primary Immunization (B-BOOST) No drug interventions prevention 3 completed NCT00984139
Persistence of Immunity Against Hepatitis B in 12-13 Year Old Adolescents After Infant Hepatitis B Vaccination prevention 4 completed NCT03931239
The Transparent Safety Study of the 5 in 1 (DTwP-rHepB-Hib) Combination Vaccine Produced by the Indian Serine Institute in Children of Viet Nam Healthy From 6 to 12 Weeks of Age in a 3-dose Regimen, the Interval Between Doses is 4 Weeks No drug interventions prevention Not Available completed NCT01177722
A Study of DTaP-IPV-Hep B-PRP-T Vaccine Given With Prevenar™ and Rotarix™ in Healthy Latin American Infants prevention 3 completed NCT02139722
Patient-Centered Care and Asian Americans No drug interventions screening Not Available completed NCT03248622
Hepatitis B Reactivation During Treatment With Direct-Acting Antiviral Agents for Chronic Hepatitis C Infection No drug interventions Not Available Not Available completed NCT02548325
Prevalence of Hepatitis B in Vallés Occidental. Observational Multicentric Study No drug interventions Not Available Not Available completed NCT00697125
Immunogenicity & Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine With Different Adjuvants prevention 2 completed NCT01358825
Study to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexa™ or Infanrix-IPV/Hib™ No drug interventions prevention 4 completed NCT03546530
The Curative Effect and Security of Interferon Combined Resveratrol on HBeAg Positive Chronic Hepatitis B Patients treatment Not Available completed NCT01847430
Evaluation of the Long-term Persistence of Immunity to Hepatitis B, in Adolescents Vaccinated in Infancy With Engerix™-B Kinder No drug interventions prevention 4 completed NCT01453348
Study to Evaluate the Safety and Immunogenicity of Combined Hepatitis A/B Vaccine With MenACWY-CRM Conjugate Vaccine prevention 3 completed NCT02850848
Pharmacokinetics of Two Formulations of Entecavir treatment 4 completed NCT02610348
Anti-Hep B Antibodies at Age 12 to 18 Months After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine Concomitantly With Prevnar® at 2, 4 and 6 Months of Age No drug interventions other Not Available completed NCT00926757
Prophylactic Use of Entecavir for Non-Hodgkin's Lymphoma Patients With Resolved Hepatitis B prevention 4 completed NCT00657657
Safety and Immunogenicity of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine No drug interventions prevention 4 completed NCT05181826
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer No drug interventions Not Available Not Available recruiting NCT00998426
Evaluating Blood Glucose Levels During Infusion With HepaGam B (HBIG) in Post-liver Transplant Patients supportive_care 4 completed NCT00332566
Assess Immunogenicity, Reactogenicity, Safety of a Booster of GSK Biologicals DTPw-HBV/Hib Kft Compared to DTPw-HBV/Hib prevention 3 completed NCT06368466
A Study to Evaluate Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Sites No drug interventions screening Not Available active_not_recruiting NCT04625166
Combi-elastography Assessment of Chronic Liver Disease Multi-center Study No drug interventions Not Available Not Available unknown_status NCT02135666
Evaluation of the Long-term Hepatitis A and B Antibody Persistence in Healthy Adult Subjects, Primed 16 to 20 Years Earlier With GSK Biologicals' Combined Hepatitis A and B Vaccine, Twinrix® (SB208127) in Study HAB-084 (208127/084) No drug interventions prevention 4 withdrawn NCT02421666
A Comparative Trial of Improving Care for Underserved Asian Americans Infected With HBV No drug interventions supportive_care Not Available completed NCT03919565
Optimized Treatment of Peginterferon Alfa 2a/2b in Anti-virus Treatment Naive Patients With HBV Related Liver Fibrosis treatment Not Available unknown_status NCT05275465
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HH-006 in Healthy Volunteers No drug interventions treatment 1 completed NCT00362674
Durability of Antiviral Activity in Chronic HBV Patients Who Showed Complete Response in L-FMAU-301,302 or 303 Trial No drug interventions Not Available Not Available completed NCT02186574
Tenofovir to Prevent HBV Reactivation treatment 3 unknown_status NCT03025074
Blood Collection Biorepository for Liver Disease Research No drug interventions Not Available Not Available recruiting NCT00313274
Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patients With HBeAg(-) Chronic HBV treatment 3 terminated NCT00244374
A Randomized Trial of Vaccine Adherence in Young Injection Drug Users prevention Not Available completed NCT02697474
Anti-Hep B Antibodies at Age 9 to 10 Years After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine. prevention 3 completed NCT02713620
Hepatitis B Vaccination in HIV-infected Adults No drug interventions prevention 4 completed NCT03285620
A Study of AL-034 to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses in Healthy Participants treatment 1 completed NCT01357720
Study to Assess if Quinvaxem Can be Interchanged With Other Pentavalent Vaccines During Standard Childhood Vaccination No drug interventions prevention 4 completed NCT01681420
Improving Blood Safety and HIV Testing in Brazil No drug interventions prevention Not Available completed NCT01998620
Efficacy and Safety of S-adenosyl-L-methionine in Treatment of Chronic Hepatitis B Patients With Cholestasis treatment 4 unknown_status NCT04195282
RL-1 Novel Human-derived Bio-artificial Liver Treatment in Patients of HBV Related ACLF No drug interventions treatment Not Available unknown_status NCT03567382
Arresting Vertical Transmission of Hepatitis B Virus prevention 4 completed NCT01973582
Hepatitis B Seroepidemiology Among Young Adults No drug interventions Not Available Not Available unknown_status NCT00440531
Study of Recombinant Modified Process Hepatitis B Vaccine in Older Adults (V232-059)(COMPLETED) prevention 3 completed NCT00154531
Identification of Biomarkers Associated With Human Hepatocellular Carcinoma by SELDI No drug interventions Not Available Not Available unknown_status NCT00697931
Immunogenicity and Reactogenicity of MPL Adjuvanted Recombinant Hepatitis B- Vaccine and Engerix™-B in Adult Non-Responders prevention 3 completed NCT03343431
Antiviral Prophylaxis and Infant Vaccination to Prevent Perinatal Hepatitis B Infection prevention 3 active_not_recruiting NCT00401531
Comparison of a DTaP-IPV-HB-PRP~T Combined Vaccine to Infanrix™-Hexa, When Administered With Prevnar® in Thai Infants prevention 3 completed NCT00289731
Effect of Risk Factors Likely to Influence Immuno of Combined Hepatitis A & B Vacc vs Monovalent Hepatitis A & B Vacc prevention 4 completed NCT00524173
Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis B treatment 2 terminated NCT05705427
The COMBAT HBV Feasibility Trial prevention 4 recruiting NCT00383227
Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years prevention 3 completed NCT00879827
Immunogenicity and Reactogenicity of GSK Bio DTPa-HBV-IPV and Hib Vaccines When Coadministered to Healthy Infants prevention 3 completed NCT03579576
Simplified Antiviral Treatment Strategy for Hepatitis C in Myanmar No drug interventions Not Available Not Available completed NCT02032160
A Study to Characterise Immune Responses Following Immunisations With "Fendrix" or "Engerix B" Hepatitis B Vaccines basic_science Not Available completed NCT02957994
TAF Switch Study in Hepatitis B Monoinfection treatment 4 unknown_status NCT02889094
French HIV-HBV Cohort No drug interventions Not Available Not Available unknown_status NCT00645294
Open Label Study of Pharmacokinetics and Safety of Dose of Adefovir Dipivoxil in Children and Adolescents With HBV Not Available 1 / 2 completed NCT00168194
Cellular Immune Responses to Hepatitis B Virus (HBV)- Longitudinal Follow up and Natural History No drug interventions Not Available Not Available completed NCT01124591
Brief Intervention for Drug Misuse in the Emergency Department No drug interventions treatment 2 completed NCT00383591
Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years prevention 3 completed NCT00696891
Study Comparing Immunogenicity, Reactogenicity and Safety of GSK Bios' HBV-MPL Vaccine With That of Engerix™-B in Adults No drug interventions prevention 3 completed NCT00125762
FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy No drug interventions diagnostic Not Available completed NCT00316680
Immuno & Safety Study With 2 Formulations of DTPw-HBV/HIB When Given at Birth With Hepatitis B at 2, 4 and 6 Mths.Age. prevention 3 terminated NCT02479880
Utilization and Efficacy of Tenofovir DF in Adolescents With Chronic Hepatitis B Virus Infection other 4 terminated NCT00291980
A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Responded to Previous Hepatitis B Vaccination But Lost Antibody. prevention 3 completed NCT03957629
Optimized Treatment of Peginterferon Alfa 2a in Treatment Experienced Patients With HBV Related Liver Fibrosis treatment Not Available unknown_status NCT02577029
Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV) treatment 2 terminated NCT00412529
Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B treatment 3 completed NCT00805389
Study to Compare the Efficacy of GSK Biologicals' Adjuvants in Combination With the Antigen of the Hepatitis B Vaccine prevention 2 completed NCT00744289
Hepatitis B Acceptability and Vaccination Incentive Trial No drug interventions prevention Not Available completed NCT00404989
Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant Women. No drug interventions Not Available Not Available recruiting NCT01171989
Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose prevention 2 completed NCT00343889
Comparison of DTaP-HB-PRP~T Combined Vaccine to Tritanrix-HepB/Hib™, Both Given Concomitantly With Oral Polio Vaccine prevention 3 completed NCT00228592
HepeX-B in Post Hepatic Allografts for Treatment of End Stage Liver Disease Due to Hepatitis B Infection prevention 2 terminated NCT00289744
Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,6 Month Schedule prevention 3 completed NCT02858440
A Study to Assess the Immunogenicity and Safety of GSK Biologicals' Infanrix-IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in Russia prevention 3 completed NCT01627340
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus No drug interventions prevention 4 completed NCT00188240
Insulin Resistance Associated With Chronic Hepatitis C (CHC) and the Effect of Antiviral Therapy treatment Not Available unknown_status NCT00142740
Hepatitis B Vaccine Genetics: A Substudy of ATN 024 and ATN 025 No drug interventions Not Available Not Available completed NCT00291967
Assess Immune Response Following Primary Vaccination With Tritanrix™-HepB Vaccine Mixed With 3 Formulations of Hib-MenAC Vaccine to Infants No drug interventions prevention 2 completed NCT00307567
Multicentre Booster & Immune Memory Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine or a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children Aged 11-18 Mths, Previously Vaccinated in Study 103488 No drug interventions prevention 2 completed NCT00768001
Genetic Analysis of Liver Cancer No drug interventions Not Available Not Available terminated NCT00654901
Study of the DTaP-IPV-Hep B-PRP~T Combined Vaccine Following a Primary Series of DTacP IPV-HepB-PRP-T or Infanrix Hexa™ prevention 3 completed NCT00136604
Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m prevention 3 completed NCT03415672
Hepatitis B Vaccine for Non-responders prevention 2 completed NCT01427868
Bioequivalence of LB80380 Free Base and Maleate Salt Tablets Not Available 1 completed NCT00473668
Non-inferiority of GSK Biologicals' DTPw-HBV/Hib Compared to Two Formulations of GSK Biologicals' DTPw-HBV/Hib prevention 3 completed NCT00932269
Seroimmunity 2007 and Sub Study of the Swedish Population Regarding Vaccine Preventable Disease No drug interventions Not Available Not Available unknown_status NCT05094869
Prevention of HCC Using Mobile Phone Applications No drug interventions Not Available Not Available unknown_status NCT05457946
Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary Series No drug interventions prevention 2 / 3 not_yet_recruiting NCT00926146
Hepatitis B Virus (HBV) Prevention for Homeless at Risk for HBV/Hepatitis C Virus (HCV)/HIV No drug interventions prevention Not Available completed NCT01933412
Efficacy and Safety of Hepatitis B Vaccine in Chronic Kidney Disease Patients prevention 3 unknown_status NCT02604212
A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Positive, Chronic Hepatitis B Virus Infection treatment 2 terminated NCT00617812
Safety and Immunogenicity Study of a Liquid Pentavalent Combination Vaccine No drug interventions prevention 4 completed NCT00426712
Safety of HEPLISAV™ Hepatitis B Virus Vaccine in End-stage Kidney Failure Patients prevention 1 completed NCT04264312
Baseline Investigation of Chronic Hepatitis B Viruses Infections: Who is Eligible for Treated Criteria No drug interventions Not Available Not Available completed NCT02647281
First Time in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of GSK3389404 in Healthy Subjects No drug interventions other 1 completed NCT00348881
Study Comparing a DTaP-HB-PRP~T Combined Vaccine With Tritanrix HepB/Hib™, Concomitantly With OPV in Healthy Infants No drug interventions prevention 3 completed NCT00429481
Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine at Different Viral Concentrations in Healthy Infants prevention 2 completed NCT01732081
"Real-life" Cohort of Patients With Chronic Hepatitis B Virus Infection No drug interventions Not Available Not Available unknown_status NCT04868981
Study on the Tolerability, Pharmacodynamics and Pharmacokinetics of GST-HG141 Tablets No drug interventions treatment 1 completed NCT06147895
A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Prophylactic Hepatitis B Vaccine No drug interventions prevention 1 completed NCT01768195
Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based Immunochemotherapy treatment 4 unknown_status NCT00511095
Open-Label Study of the Safety and Immunogenicity of HEPLISAV™ Hepatitis B Virus Vaccine No drug interventions prevention 2 completed NCT03088995
Pilot Study of HIV and Hepatitis B and C Screening in Surgery No drug interventions Not Available Not Available completed NCT00380614
A Randomized Controlled Trial of Lamivudine in Acute Hepatitis B treatment 4 completed NCT01962155
Prospective Stuy in Evaluating Hepatic Fibrosis Related to Hepatitis B Virus Using Non-invasive Parameters No drug interventions Not Available Not Available completed NCT05330455
Study of GSK3965193 in Healthy Participants and Participants Living With Chronic Hepatitis B Infection No drug interventions treatment 2 recruiting NCT00155155
Studies of Immune Responses in Patients With Chronic Hepatitis B No drug interventions Not Available Not Available completed NCT00315055
Immunogenicity of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® at 2-3-4 Months Schedule prevention 3 completed NCT00414050
A Study of 2 Doses of a Hepatitis B Vaccine (V232 RECOMBIVAX HB) in Healthy Infants (V232-057) prevention 3 completed NCT03084250
The Investigation of Peginterferon Alfa-2a on Optimal in Chronic Hepatitis B Patients Who Have a High Risk of HCC treatment 4 unknown_status NCT02044523
Noninvasive Staging of Liver Fibrosis: MR vs Ultrasound No drug interventions Not Available Not Available completed NCT03312023
Ledipasvir/Sofosbuvir for Hepatitis B Virus Infection treatment 2 completed NCT02909023
Performance of the HBV ELISPOT in the Detection of the T Cellular Immune Response in Patients Infected by HBV or Cured Not Available Not Available completed NCT02288208
Phase I Safety and Tolerability Study of Birinapant in Chronic Hepatitis B treatment 1 terminated NCT02738008
Extension Study of the Safety and Efficacy of Multi-dose Intravenous ARC-520 in Patients With Chronic Hepatitis B (HBV) Infection treatment 2 terminated NCT00158808
Immune Memory Foll Pry Vaccination With DTPw-HBV/Hib Vaccine Formulation; Immuno & Reacto of Booster Dose at 15-18 Mths prevention 2 completed NCT00674908
Phase IV Interchangeability Study of a Liquid Pentavalent Combination Vaccine No drug interventions prevention 4 completed NCT01146808
Adefovir Plus Vaccination in Transplant Patients Without Hepatitis B That Receive a Core Antibody Positive Liver treatment 1 / 2 completed NCT01457508
Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib, Compared to DTPa-HBV-IPV and Hib Administered Separately prevention 3 completed NCT02540538
Safety and Immunogenicity of HBAI20 Hepatitis B Vaccine in Naive Adults and Non-responders prevention 1 completed NCT02596438
Thousand Asian American Study No drug interventions Not Available Not Available completed NCT03577938
Study on the Optimal Strategy for Acute-on-chronic Liver Failure With Integrative Treatment No drug interventions treatment Not Available completed NCT00391638
Efficacy and Tolerance of Peg-interferon Alpha 2a Added to Tenofovir and Emtricitabine in AgHBe Positive HBV-HIV Co-infected Patients treatment 2 / 3 completed NCT02511743
Knowledge and Practice of Chinese Medical Specialists Regarding Chronic Hepatitis B Virus Infection No drug interventions Not Available Not Available completed NCT01341743
Efficacy Optimizing Research of Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy treatment 4 unknown_status NCT04959643
Systematic Screening for Viral Hepatitis B and C at the PASS Consultation of the Montpellier University Hospital No drug interventions Not Available Not Available unknown_status NCT00290303
Assess if Immune Response of GSK Biologicals' Tritanrix™-HepB/Hib-MenAC Given Without or With Hepatitis B Vaccine at Birth is at Least as Good as Tritanrix™-HepB/Hiberix™ Without Hepatitis B Vaccine at Birth, When Given to Healthy Infants No drug interventions prevention 3 completed NCT00155103
Effect of Polymorphisms in the IL-1 Gene Complex on the Development of Chronic Hepatitis and Hepatocellular Carcinoma No drug interventions Not Available Not Available unknown_status NCT00845403
Antigen-specific Immune Response to Hepatitis B Virus in Utero No drug interventions Not Available Not Available unknown_status NCT04863703
Improvement of Portal Hypertension During Viral Suppression in Patients With Hepatitis Delta (IMPHROVE-D) Not Available Not Available recruiting NCT01353703
Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine prevention 3 completed NCT06058390
A Study to Evaluate the Relative Bioavailability of Subcutaneous Bepirovirsen When Delivered From a Vial or Prefilled Syringe Fitted With a Safety Syringe Device in Healthy Adult Participants No drug interventions treatment 1 completed NCT04114890
Tenofovir in Pregnancy to Prevent Mother to Child Transmission of Hepatitis B. prevention 2 completed NCT00222664
Qidong Hepatitis B Intervention Study No drug interventions prevention 4 completed NCT02749864
Study to Evaluate the Prevalence of Hepatitis C in Spain in 2015 (PREVHEP) No drug interventions Not Available Not Available completed NCT01574521
Seroepidemiologic Study of Spermatozoal Transmission of Hepatitis B Virus (HBV) No drug interventions Not Available Not Available completed NCT02275221
Immune Response in Patients With Hepatitis B and C Infection No drug interventions Not Available Not Available recruiting NCT00760721
Increasing Hepatitis B Screening Among Korean Church Attendees No drug interventions screening 3 completed NCT04023721
Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic, Hepatitis B e Antigen-negative Subjects Infected With HBV Virus and Receiving or Stopping Treatment With a NUC Inhibitor treatment 2 terminated NCT04870021
Hepatitis B Birth Dose for Newborns prevention 4 completed NCT00013702
Adefovir Dipivoxil to Treat Hepatitis B in HIV-Infected Patients treatment 2 completed NCT03973502
Application of 18F-FDOPA PET and Magnetic Resonance Spectroscopy (MRS) With HCV and PD No drug interventions diagnostic Not Available unknown_status NCT03307902
ID HBV Vaccination With Imiquimod in OBI prevention 2 / 3 completed NCT01580202
Comparison of Prophylactic Antiviral Efficacy in Patients Undergoing Chemotherapy: Entecavir Versus Lamivudine treatment 3 completed NCT06360484
Prevalence and Clinical Characterization of Hepatitis D Virus (HDV) Infection Among Sudanese Patients With Hepatitis B Virus No drug interventions Not Available Not Available completed NCT03933384
Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B treatment 4 recruiting NCT03155984
Optimizing HBV Management During Anti-CD20 Antibodies No drug interventions Not Available Not Available completed NCT01317784
Behavioral Science Aspects of Rapid Test Acceptance No drug interventions screening Not Available completed NCT02959684
Strategic Screening for Infectious Diseases (Tuberculosis, HIV, HBV, HCV) Amongst Migrants in France No drug interventions Not Available Not Available unknown_status NCT00451984
Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2 prevention 3 unknown_status NCT00376779
Immunogenicity and Safety of a DTPa-HBV-IPV/Hib Vaccine Given at 2, 3 and 4 Months of Age prevention 2 completed NCT01337479
A Phase IIIb: Long-Term Outcomes for Hepatitis B (HepB) Patients in Some Previous Entecavir (ETV) Trials No drug interventions Not Available Not Available completed NCT03535779
Characterisation of Human B Cell Maturation in Response to Vaccination Not Available Not Available completed NCT00313287
Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patient With Chronic HBV treatment 3 terminated NCT04310787
Long-term Prognosis of Patients With Hepatitis B Related Acute-on-chronic Liver Failure No drug interventions Not Available Not Available unknown_status NCT01263587
Hepatitis B Research Network Adult Cohort Study No drug interventions Not Available Not Available completed NCT00317187
Safety Study of a Vaccine Against Meningitis in Infants (2,4 & 6 Months Age) After a Birth Dose of Hepatitis B. prevention 3 completed NCT01790633
Pilot Study Evaluating the Use of Simultaneous HBV, HCV, and HIV Rapid Tests No drug interventions screening Not Available completed NCT03826433
hUC Mesenchymal Stem Cells (19#iSCLife®-LC) in the Treatment of Decompensated Hepatitis b Cirrhosishepatitis b Cirrhosis No drug interventions treatment 1 recruiting NCT02732054
Hepatitis B Vaccination in HIV-infected Adults With Low CD4 Cell Counts prevention 4 completed NCT01590654
A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection treatment 1 completed NCT02759354
Long-term Persistence of Hepatitis B and Pertussis Antibody Responses in Healthy 4 to 5 Year Old Children Previously Vaccinated With Vaxelis® or INFANRIX® Hexa (V419-012) No drug interventions prevention 3 completed NCT00291954
Compare the Immune Response & Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine vs Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis & Dialysis Patients Who Did Not Respond to Previous Hepatitis B Vaccination prevention 3 completed NCT00000654
The Tolerance of HIV-Infected Patients With Herpes Group Virus Infections to Oral Doses of FIAU treatment 2 completed NCT01732354
Study for Consolidation Period of Chronic Hepatitis B No drug interventions Not Available Not Available completed NCT00489151
A Randomized Study Comparing Lamivudine Versus Adefovir Dipivoxil for Prevention of zHBV Reactivation in HBsAg Seropositive Patients Undergoing Cytotoxic Chemotherapy treatment Not Available unknown_status NCT00404651
Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy Infants prevention 3 completed NCT01090453
Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants prevention 2 completed NCT00831753
Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Infanrix®Hexa in Healthy Peruvian Infants prevention 3 completed NCT00219453
Pilot Safety Study to Determine the Ability of the Protector Cap Jet Injector to Prevent Cross-Contamination No drug interventions prevention 1 completed NCT03410953
Vaccination Adjuved Against Hepatitis B in SNS Workers Typed as no Responders to Conventional Vaccines prevention 4 completed NCT04783753
Drug-Drug Interaction Study Between EDP-514, Itraconazole, Carbamazepine, and Quinidine in Healthy Subjects basic_science 1 completed NCT02186977
Proof Of Concept : Immunogenicity and Safety of hepB Injection in the Dermis Using VAX-ID prevention 1 completed NCT00880477
Immunogenicity and Safety of Primary and Booster Vaccination With DTPa-HBV-IPV/Hib Vaccine prevention 3 completed NCT03771677
To Optimize the Therapeutic Pathway of Peginterferon Treatment in Patients With CHB Based on IFNA2p.Ala120Thr /ISGs. treatment Not Available recruiting NCT03365947
Study of ARO-HBV in Normal Adult Volunteers and Patients With Hepatitis B Virus (HBV) treatment 1 / 2 completed NCT01457547
Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination Course prevention 4 completed NCT01074645
Randomized Controlled Trial of Tenofovir in Patients of Reactivation of Hepatitis B Presenting as Acute on Chronic Liver Failure treatment 4 completed NCT00662545
Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection treatment 4 completed NCT00133445
Pentavalent DTaP-Hep B-IPV No drug interventions prevention 2 completed NCT00516945
A Study to Investigate Whether the Immediate Use or Deferred Use of an Anti-viral Drug Lamivudine Will Help to Better Safe-guard the Delivery of Chemotherapy in Patients With Cancer Who Are Also Hepatitis B Carriers treatment Not Available completed NCT04531098
A Bridging Study: Comparing Two Lots of Sci-B-Vac™ and Engerix-B in Healthy Adults prevention 3 completed NCT01453998
Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744) prevention 2 completed NCT03345498
Entecavir for Decompensated HBV Cirrhosis Not Available Not Available completed NCT03702998
Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population No drug interventions Not Available Not Available completed NCT00150098
Project UNITY - HIV Risk Reduction and Vaccine Education Interventions No drug interventions Not Available Not Available completed NCT04196998
Three Types of Nucleotide/Nucleoside Analogues Therapy in Patients With Hepatitis b Virus Related Compensated Cirrhosis treatment Not Available unknown_status NCT01138098
Evaluation of Antibody Persistence and Immune Memory Against the Hepatitis B Antigen in Previously Vaccinated Children No drug interventions prevention 4 completed NCT02995005
Tenofovir in Early Pregnancy to Prevent Mother-to-child Transmission of Hepatitis B Virus prevention 1 / 2 completed NCT03920605
Optimized Treatment of Peginterferon Alfa 2a/2b in Treatment Experienced Patients With HBV Related Liver Fibrosis treatment Not Available unknown_status NCT01767597
Application of HBV Rapid Tests as a Tool for Wide-Use Screening No drug interventions screening Not Available completed NCT03692897
An Observational Study of Patients With Chronic Hepatitis B (CHB) Infection No drug interventions Not Available Not Available recruiting NCT00411697
Persistence of Hepatitis B Antibody Levels & Immune Response to a Hepatitis B Vaccine Challenge No drug interventions prevention 4 completed NCT01463683
Modified Process Hepatitis B Vaccine in Japanese Young Adults (V232-062) prevention 3 completed NCT01349283
Immunogenicity and Safety of the Hepatitis B Vaccine Hepavax-Gene TF and a Comparator Hepatitis B Vaccine in Newborns prevention 3 completed NCT00383383
Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years prevention 3 completed NCT02052661
This Study Aims to Determine the Long-term Persistence of Antibodies Against Hepatitis B and to Evaluate the Immunogenicity and Safety of Hepatitis B Vaccine in Adolescents Vaccinated in Infancy With Infanrix™ Hexa prevention 4 completed NCT00322361
Modified Process Hepatitis B Vaccine in Healthy Neonates (V232-056) prevention 2 completed NCT05768061
HBV Reactivation in Anti CD20 Treatment No drug interventions Not Available Not Available active_not_recruiting NCT00317161
Immunogenicity & Safety Study of a Vaccine Against Meningitis in Infants (2,4,6 Months) After a Hepatitis B Birth Dose. No drug interventions prevention 3 completed NCT04971928
Phase 1 Study of GSK3228836 Pharmacokinetics in Participants With Hepatic Impairment treatment 1 completed NCT04289428
Evaluation of Novel Point of Care Hepatitis B Diagnostic Assays No drug interventions Not Available Not Available withdrawn NCT00313911
Safety of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and 6 Months. prevention 3 completed NCT04503993
Healthy Planet Hepatitis B No drug interventions screening Not Available completed NCT01948193
Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine in Indian Infants Previously Given a Dose of Hepatitis B Vaccine at Birth prevention 3 completed NCT00013871
Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs prevention Not Available completed NCT04240678
The Effect of an Electronic Medical Record (EMR) Alert on Hepatitis B Screening No drug interventions screening Not Available completed NCT00970307
Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age prevention 2 completed NCT05002907
Epidemiology of Hepatitis B, C and D and HIV Along the Maroni River Bordering French Guiana and Suriname (MaHeVi) No drug interventions Not Available Not Available completed NCT05690607
Small Volume Blood Testing Validity and Acceptability for HIV-1 and Hepatitis B (TINIES for BBVs) No drug interventions Not Available Not Available not_yet_recruiting NCT01645007
Prevalence of Hepatitis B Infection in the Galilee Region, Israel No drug interventions Not Available Not Available withdrawn NCT00023309
Lamivudine and Adefovir to Treat Chronic Hepatitis B treatment 2 completed NCT00514709
Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB PRP~T Combined Vaccine in Filipino Infants prevention 3 completed NCT04906109
Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of DA-2803 in Healthy Subjects treatment 1 completed NCT02152709
Study of Evaluating Safety and Immunogenicity of 10µg/0.5ml Hepatitis B Vaccine prevention 3 completed NCT00158756
Immune Response Post Pry Vaccination of 2 Formulations of DTPw-HBV Vaccine Given With Rotavirus Vaccine to Infants prevention 3 completed NCT04544956
A Mechanistic Study of GSK3228836 With Fine Needle Aspiration (FNA) in Participants With Chronic Hepatitis B treatment 2 completed NCT00445185
Study Evaluating Persistence of Anti-HBs Antibodies in Uraemic Patients Receiving Henogen's HBV Vaccine, or Fendrix™ prevention 3 completed NCT00096785
Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection treatment 3 completed NCT04177485
Evaluating a Caregiver SMS Reminder Intervention to Reduce Immunization Drop-out in Arua, Uganda No drug interventions prevention Not Available completed NCT01610115
HBV DNA Levels During Pregnancy in Chronic Hepatitis B No drug interventions Not Available Not Available unknown_status NCT01884415
Phase III, Study to Evaluate the Efficacy of Two Different HBV Vaccination Schemes in Patients With Hepatic Cirrhosis treatment 3 completed NCT01590615
Registry Study for Patients With Chronic HBV Receiving Nucleotide Therapy No drug interventions Not Available Not Available completed NCT04199715
Safety and Efficacy of a Hepatitis B Vaccine in Immunosuppressed Patients prevention 1 completed NCT01298037
HBRN: Immune Regulation and Costimulation in Natural History of Chronic Hepatitis B No drug interventions Not Available Not Available active_not_recruiting NCT00463437
Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines prevention 3 completed NCT02760537
Lay Health Worker Model to Reduce Liver Cancer Disparities in Asian Americans No drug interventions prevention Not Available completed NCT02982837
To Study the Effect of Adding on Pegylated Interferon (PEG-INF) Therapy for Patients Diagnosed With Chronic Hepatitis B No drug interventions treatment 4 unknown_status NCT00722332
Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients prevention 4 completed NCT04843852
TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B treatment 1 withdrawn NCT02247752
Follow-up of HBsAg Inactive Carriers Study No drug interventions prevention Not Available completed NCT00362700
Safety and Efficacy Study of Retreated Clevudine in Chronic HBV Patients Who Received Clevudine in L-FMAU-201 treatment 2 terminated NCT01263600
Hepatitis B Research Network Pediatric Cohort Study (HBRN) No drug interventions Not Available Not Available completed NCT05686759
A Study to Investigate the Safety and Efficacy of Undiluted Intravenous Infusion of I.V.-Hepabig Inj. prevention 3 recruiting NCT01105559
Antibody Persistence in Healthy Children After Primary and Booster DTaP-IPV-Hep B-PRP-T Vaccine or Control Vaccine No drug interventions Not Available Not Available completed NCT06421259
Descriptive Analysis of Changes in Hepatitis B Markers in People Living With HIV on Injectable Therapy. No drug interventions Not Available Not Available not_yet_recruiting NCT03123159
Clinical Performance Evaluation of DxN HBV Assay No drug interventions Not Available Not Available terminated NCT04431375
Efficacy of Addition of Fecal Microbiota Transplant (FMT) and Plasma Exchange to Tenofovir in Comparison to Monotherapy With Tenofovir in ACLF-HBV treatment Not Available unknown_status NCT00197275
Lot-to-lot Consistency of Tritanrix™-HepB/Hib-MenAC & Its Non-inferiority vs Tritanrix™-HepB/Hiberix™ in Infants No drug interventions prevention 3 completed NCT00697775
Safety and Immunogenicity of GSK Bio's Candidate HBV-MPL Vaccines Compared to Engerix™-B, in Healthy Adolescents No drug interventions prevention 2 completed NCT00289770
Long-term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Mth Schedule in Healthy Adults prevention 3 completed NCT00107042
Effectiveness of Two Hepatitis B Vaccines in HIV-negative Youths prevention 2 completed NCT02025842
Hepatitis B Virus HBeAg-negative Genotype D Patients and Hepatocellular Carcinoma No drug interventions Not Available Not Available completed NCT00697242
Comparison of Immuno, Reacto and Safety of Recombinant Hepatitis B Vaccine With or Without MPL in Healthy Older Adults prevention 3 completed NCT00169442
Immune Memory of DTPw-HBV/Hib Vaccine Following Primary Vaccination, Immuno & Reacto of a Booster Dose Given in Infants prevention 3 completed NCT01046799
Prevention of Hepatitis B Virus Reinfection After Liver Transplantation With Entecavir treatment 3 completed NCT02402699
Ipilimumab 60-month Pharmacovigilance Protocol for Advanced Melanoma Patients Who Are Hepatitis B and/or Hepatitis C Virus Positive in Taiwan No drug interventions Not Available Not Available completed NCT04490499
A Hepatitis B Vaccine Challenge Study After Previous Vaxelis® Vaccination (V419-013) prevention 3 completed NCT00097006
Retrovirus Epidemiology Donor Study-II (REDS-II) No drug interventions Not Available Not Available completed NCT05086536
Re-compensation and Its Clinical Characteristics in HBV Decompensated Cirrhosis No drug interventions Not Available Not Available unknown_status NCT00362336
Comparison of DTaP-IPV-Hep B-PRP~T Combined Vaccine to CombAct-HIB® Concomitantly Given With Engerix B® Paediatric and OPV prevention 3 completed NCT00767936
Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma No drug interventions Not Available Not Available terminated NCT03425513
Hepatitis B Virus Prevalence and Risk Factors in Belgium No drug interventions Not Available Not Available completed NCT01856413
A Clinical Trial of Zutectra in Patients Who Recently Received a Liver Transplant prevention 3 completed NCT03932513
Evaluating the Effects of Inarigivir on Immune Response and Viral Markers in Chronic Hepatitis B Patients treatment 2 terminated NCT01333813
Hepatitis B Antibody Persistence and Immune Response to Hepatitis B Vaccine Challenge in Previously Vaccinated Children prevention 4 completed NCT02826018
A Study of ALN-HBV in Healthy Adult Volunteers and Non-cirrhotic Patients With Chronic Hepatitis B Virus (HBV) Infection No drug interventions treatment 1 terminated NCT00289718
Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Month Schedule prevention 3 completed NCT03798119
TAF Switch in F3/4 CHB pt With Partial Response to NUC (ESTAB-AFPVR) treatment 4 unknown_status NCT01203319
The Immunogenicity and Safety of 60mcg/30mcg Recombinant Hepatitis B Vaccines in People Who Failed to Respond to Routine Administration of Hepatitis B Vaccines prevention 2 / 3 completed NCT01329419
HEPSERA Post Marketing Surveillance Not Available Not Available completed NCT01590641
A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B treatment 1 completed NCT04710641
Radomised Phase II Study of MTL-CEBPA Plus Sorafenib or Sorafenib Alone treatment 2 active_not_recruiting NCT00291941
A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to GSK Biologicals Adjuvanted Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Have Not Been Exposed to Hepatitis B. prevention 3 completed NCT00124241
An Extension Study of Telbivudine, Lamivudine or Telbivudine Plus Lamivudine in Patients With Chronic Hepatitis B treatment 2 completed NCT01362517
Study of Quinvaxem for Vaccination Against Diphtheria, Pertussis, Tetanus, Hepatitis B and Diseases Caused by Haemophilus Influenzae Type B No drug interventions treatment 3 completed NCT00696917
Safety and Immunogenicity of 3 Lots of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Volunteers ≥ 15y No drug interventions prevention 3 completed NCT04297917
First in Human Study of ChAdOx1-HBV No drug interventions treatment 1 completed NCT06379334
Discovering Urinary Protein Biomarkers for Hepatocellular Carcinoma in Chronic Hepatitis B Population No drug interventions Not Available Not Available active_not_recruiting NCT01300234
Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) 300mg in Chinese Subjects With Chronic Hepatitis B (CHB) treatment 3 completed NCT03625934
Study to Evaluate Induction of HBV Virus Neutralizing Antibodies Using VVX001 No drug interventions treatment 2 unknown_status NCT00501124
Safety and Efficacy Study of Clevudine Compared With Clevudine and Vaccine in Patient With HBeAg(+) Chronic HBV treatment 4 completed NCT04676724
Study of Sequential GSK3228836 and Peginterferon Treatment in Participants With Chronic Hepatitis B (CHB) treatment 2 completed NCT05390424
Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood Spot No drug interventions diagnostic Not Available unknown_status NCT01000324
Antibody Persistence & Immune Memory in Healthy Adults Previously Vaccinated With Twinrix Adult prevention 4 completed NCT04893616
Cameroon HepB Birth Dose Feasibility Pilot No drug interventions health_services_research Not Available completed NCT00480116
Consistency Study of Three Lots of Henogen's Adjuvanted Hepatitis B Vaccine When Given in 0, 1 Month Schedule treatment 3 completed NCT02799316
Is Hepatitis B Surface Antigen (HB s Ag) Enough Alone as a Screening Test Before Immunosuppressive Therapies? No drug interventions diagnostic Not Available unknown_status NCT00697216
Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Adults (15-40 Yrs). No drug interventions prevention 3 completed NCT05952596
A Study to Evaluate Safety and Immunogenicity of APV006 in Healthy Adults No drug interventions prevention 1 not_yet_recruiting NCT02751996
A Study Evaluating the Safety, Pharmacokinetics, and Antiviral Efficacy of SB 9200 in Subjects Infected With Chronic HBV treatment 2 completed NCT03027258
Point-of-Delivery Prenatal Test Results Through mHealth to Improve Birth Outcome No drug interventions other Not Available unknown_status NCT00197158
Comparison of Monodose and Multidose Presentations of GSK Biologicals' Hepatitis B Vaccine in Terms of Immune Response prevention 4 completed NCT03083158
Immunity to Hepatitis B Vaccine basic_science 4 completed NCT03825458
Creation of a Cohort for the Quantitation and Characterization of Circulating Viral RNAs as a New Biomarker of Hepatitis B Functional Cure. No drug interventions Not Available Not Available recruiting NCT00627458
Immunogenicity and Reactogenicity of a Booster Dose of GSK Bio's DTPa-HBV-IPV/Hib Vaccine prevention 2 completed NCT00782158
Hepatitis B and HIV Co-Infection in Patients in Uganda No drug interventions Not Available Not Available completed NCT00496158
Efficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B Virus treatment 3 terminated NCT03829735
Neonatal Vaccination Against Hepatitis B in Africa - Sero-survey in Senegal No drug interventions diagnostic Not Available withdrawn NCT00317135
Safety Study of a Vaccine Against Meningitis in Infants ( 2,4 & 6 Months Age) After a Birth Dose of Hepatitis B. prevention 3 completed NCT01878435
Randomized Controlled Trial of the Impact of Mobile Phone Delivered Reminders and Travel Subsidies to Improve Childhood Immunization Coverage Rates and Timeliness in Western Kenya No drug interventions other Not Available completed NCT01810835
Prevention of Hepatitis B Virus Mother-to-child Transmission by Serovaccination. No drug interventions Not Available Not Available completed NCT05272735
HBV Vaccination of Healthy Volunteers to Evaluate the Composition of Germinal Centers basic_science 4 recruiting NCT02096263
Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants prevention 3 completed NCT00033163
A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIV treatment 2 completed NCT01606163
Safety and Pharmacokinetics Study of Healthy Male Adults When Repeatedly Administered Through Intravenous Injection prevention 1 completed NCT00702663
Seroprevalence of Hepatitis B Infection and Effect of Booster Response Amongst Taiwanese Young Adults No drug interventions Not Available Not Available unknown_status NCT02057263
The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults prevention 1 completed NCT04179786
A Study to Qualify an In-house Reference Standard Batch of Sci-B-Vac™ No drug interventions prevention 4 completed NCT02791386
Rescue Treatment Pattern, Drug Resistance Recurrence, and Direct Medical Costs Associated With Chinese Patients With Chronic Hepatitis B and Drug Resistance to Nucleot(s)Ide Analogue Therapy No drug interventions Not Available Not Available completed NCT02366286
Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants No drug interventions Not Available Not Available completed NCT06058286
MENJAGA: Continuous Quality Improvement for Antenatal HIV, Syphilis and Hepatitis B Testing in Indonesia No drug interventions health_services_research Not Available not_yet_recruiting NCT00693186
A Study to Assess the Anamnestic Immune Response in Healthy 4 to 7 Year-old Children After a Primary Vaccination Series With Either HEXAVAC® or INFANRIX®-HEXA prevention 3 completed NCT00240539
Long Term Follow-Up Study 16-20 Years After Hepatitis B Vaccination in Newborns of Mothers Who Were Seropositive for Hepatitis B Envelope Antigen (HBeAg) & Hepatitis B Surface Antigen (HBsAg) No drug interventions prevention 4 completed NCT03489239
Entecavir to TAF Switch other 3 active_not_recruiting NCT02797522
A Study of ARC-521 Injection in Normal Adult Volunteers and Patients With Chronic Hepatitis B (CHB) treatment 1 terminated NCT05839522
Australian Hepatitis and Risk Survey in Prisons No drug interventions Not Available Not Available recruiting NCT00456625
Immune Response to Hepatitis B Vaccine Challenge Dose in Subjects Who Received a Primary Neonatal Hepatitis B Vaccine. prevention 4 completed NCT04109625
Preliminary Validation of an in Vitro Diagnosis-medical Device for Hepatitis B Screening No drug interventions other Not Available completed NCT01599130
Efficacy of Peg-interferon α-2a in Hepatitis B Patients Treated by Entecavir Without HBeAg Loss treatment Not Available unknown_status NCT03566030
Switching From Tenofovir Disoproxi Fumarate to Tenofovir Alafenamide in Chronic Hepatitis B Patients With Antiviral Resistance Not Available Not Available unknown_status NCT02434848
A Pilot Study Comparing the Immunogenicity of Fendrix vs. Double-dose Engerix B in HIV-infected Non-responders to Standard Hepatitis B Vaccination Courses prevention 2 / 3 completed NCT00877357
Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination Vaccine No drug interventions prevention 4 unknown_status NCT01917357
A Comparison of the Immunogenicity and Safety of Quinvaxem in Mono-dose Vials and Uniject No drug interventions prevention 3 completed NCT04083157
Intra-dermal With Topical Imiquimod Pretreatment Versus Intra-muscular Hepatitis B Vaccination in IBD Patients treatment 2 / 3 completed NCT01796457
HBRN: Immune Regulation and Costimulation in Natural History and Therapeutic Outcome of Chronic Hepatitis B No drug interventions Not Available Not Available active_not_recruiting NCT02203357
A Randomized,Parallel-group Clinical Trial of Hepatitis B Vaccine With Different Dosages and Schedules in Healthy Adults prevention 4 completed NCT01548326
Effects of Short-term Atorvastatin Treatment on Vaccination Efficacy in Nonresponder Persons to Hepatitis B Vaccine prevention 4 unknown_status NCT04309526
Safety, Tolerability and Pharmacokinetics of NCO-48 Fumarate in Healthy Subjects No drug interventions treatment 1 completed NCT00240526
LT F-up Study 16-20 Yrs After Vaccine Dose of Hepatitis B With/Without HBIg in Newborns to HBeAg+ Mothers prevention 4 completed NCT04620226
UHN Inpatient Hepatitis C & B Screening No drug interventions screening 4 recruiting NCT03362866
Epidemiology of Hepatitis B, C and Delta in Reunion Island No drug interventions Not Available Not Available unknown_status NCT00697866
Consistency of 3 Consecutive Lots of a Novel HBV Vaccine With Single-blind Safety Evaluation Using Engerix™-B as Control No drug interventions prevention 3 completed NCT00366366
To Evaluate Immunogenicity & Safety of GSK Bio's DTPa-HBV-IPV/Hib (Mixed Vaccine) and DTPa-IPV/Hib + HBV Vaccines prevention 3 completed NCT04568265
A Clinical Study of APG-1387 in Combination With Entecavir in Patients With Chronic Hepatitis B treatment 2 recruiting NCT01131065
Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipients prevention 3 completed NCT02055365
Pilot Study: Gene Expression Profiling of Immune Response to HBV Vaccination in Healthy Volunteers basic_science Not Available completed NCT01500265
Assessment and Monitoring of Renal Proximal Tubular Tolerance of Nucleoside and Nucleotide Analogues Using Early Screening Tools in Patients Chronically Mono-infected With Hepatitis B Virus No drug interventions Not Available Not Available completed NCT02779465
Oral Vitamin D Treatment for the Prevention of Hepatocellular Carcinoma prevention 4 not_yet_recruiting NCT01344174
A Study Evaluating the Efficacy of Glucocorticoids in Patients With Pre-ACLF-HBV treatment Not Available unknown_status NCT02169674
Hepatitis B Booster Study in Adolescence No drug interventions prevention 4 completed NCT01777074
Acceptability of Hepatitis B Vaccination in General Practitioners and Paediatricians No drug interventions Not Available Not Available completed NCT03149874
Accelerated Vaccination Schedule Against Hepatitis B Virus With Combined Hepatitis A and B Vaccine Among Hemodialysis Patients prevention Not Available completed NCT00317174
A Study to Assess Antibody Persistence, Boostability & Safety in Previously Primed Subjects. No drug interventions prevention 2 completed NCT02153320
Study to Evaluate the Persistence of the Cellular and Humoral Immune Response Following Vaccinations With GlaxoSmithKline (GSK) Biologicals' Candidate Vaccines Containing HBsAg and Different Adjuvants in Healthy Adult Volunteers No drug interventions prevention 1 completed NCT01765231
Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With Lymphoma treatment 4 unknown_status NCT00699231
Evaluation of Immunogenicity, Reactogenicity and Safety of HBV-MPL Vaccine vs Engerix™-B, in Haemodialysis Patients No drug interventions prevention 1 completed NCT00994773
Simvastatin for the Treatment of Chronic Hepatitis B treatment 1 completed NCT05551273
Study of Oral TLR8 Agonist Selgantolimod on HBsAg in Participants With Both Chronic Hepatitis B and HIV treatment 2 recruiting NCT05561673
A Study on the Safety and Immune Response of AS37 Together With Hepatitis B Antigen in Adults Aged 18-45 Years prevention 1 active_not_recruiting NCT00362427
Study of PR5I, a Pediatric Combination Vaccine With Enhanced Hepatitis B Component Given Concomitantly With Prevnar® prevention 2 completed NCT00329576
Evaluate Immune Response Approximately 5 to 6 Years After Receiving Different Formulations of GSK Bio Hep B Vaccine Not Available 4 completed NCT05144776
Evaluation of Hepatitis B Virus (HBV) DNA Test as Point of Care Tool No drug interventions Not Available Not Available recruiting NCT01251276
Hepatitis B Challenge Dose in Adults (V232-059-10) prevention 3 completed NCT00524576
Challenge Dose of Hepatitis B Vaccine in Subjects Who Previously Received Engerix™-B Vaccine prevention 4 completed NCT01457560
Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib Vaccine Followed by the Same Vaccine and Oral Polio Vaccine prevention 3 completed NCT05483894
Atorvastatin Use and Portal Hypertension in Patients With Hepatitis B Virus-related Liver Cirrhosis: A Randomized Controlled Trial treatment 2 not_yet_recruiting NCT03511794
Effectiveness of the Hepatitis B Vaccine Post-Hematopoietic Stem Cell Transplant No drug interventions Not Available Not Available completed NCT01782794
Acceptability of Hepatitis B Vaccination in General Population No drug interventions Not Available Not Available completed NCT00822991
Sonazoid Enhanced Liver Cancer Trial for Early Detection No drug interventions diagnostic Not Available unknown_status NCT02428491
Immunogenicity and Safety of Sanofi Pasteur's Combined Vaccine Given as a Three-Dose Primary Series at 2, 3,4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months of Age in Vietnamese Infants Who Previously Received a Dose of Hepatitis B Vaccine at Birth or Within 1 Week After Birth prevention 3 completed NCT01987791
Observation Study of Prednisone and Cyclosporine in Treatment of Thrombocytopenia in Hepatitis B Cirrhosis No drug interventions Not Available Not Available unknown_status NCT02148562
Assessment of Hepatitis B Virus Intra-host Population and Host-specific Immune Marker Diversity No drug interventions Not Available Not Available unknown_status NCT00000580
Interruption of Maternal-to-Infant Transmission of Hepatitis B by Means of Hepatitis B Immune Globulin prevention 3 completed NCT05957380
Clinical Study to Evaluate the Efficacy and Safety of DA-2803 in Chronic Hepatitis B Patients No drug interventions treatment 4 recruiting NCT00152880
Apoptosis and Hepatitis B: The Role of Apoptosis in Patients Who Are HBeAg Negative No drug interventions Not Available Not Available unknown_status NCT04449029
A Study of GSK3228836 in Participants With Chronic Hepatitis B (CHB) treatment 2 completed NCT02853929
Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery prevention 4 completed NCT00697229
Immunogenicity & Reactogenicity of HBV-MPL Vaccine and Engerix™-B in Healthy Adults Following 2 Different Schedules No drug interventions prevention 2 completed NCT04193189
B-Enhancement of HBV Vaccination in Persons Living With HIV (BEe-HIVe): Evaluation of HEPLISAV-B prevention 3 completed NCT04585789
A Study to Assess Intrahepatic and Peripheral Changes of Immunologic and Virologic Markers in Chronic Hepatitis B Virus Infection other 2 completed NCT01863589
Drug Use Investigation for HEPSERA (Adefovir) Tablet Not Available Not Available completed NCT00381992
Risk Assessment of Long-Haul Truck Drivers No drug interventions Not Available Not Available completed NCT04366492
HBV/HCV/HIV in Belgian Prisons No drug interventions screening Not Available completed NCT01106092
Study to Evaluate the Immunogenicity and Reactogenicity of a Booster Dose of GSK2036874A Vaccine in Healthy Toddlers No drug interventions prevention 2 completed NCT06316492
A Study Done by a Demonstrator and Two Professors in Public Health and Community Medicine Department in Faculty of Medicine in Assiut and New Valley University to Assess Knowledge, Attitude ,and Practice of Rural Population in a Remote Governorate ( New Valley ) Towards Hepatitis B and C Viruses No drug interventions Not Available Not Available not_yet_recruiting NCT01931644
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions No drug interventions Not Available Not Available completed NCT00128544
Telbivudine Versus the Combination of Telbivudine and Valtorcitabine in Patients With Chronic Hepatitis B treatment 2 completed NCT02108444
Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients No drug interventions Not Available Not Available completed NCT00697840
Safety, Immunogenicity and Reactogenicity of Recombinant Hepatitis B Vaccine (Adjuvanted & New Formulation) and Engerix™-B prevention 3 completed NCT01163240
Epidemiological Study in Children and Adolescents With Chronic Hepatitis B No drug interventions Not Available Not Available completed NCT01983540
Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination prevention 3 completed NCT00160940
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis No drug interventions Not Available Not Available unknown_status NCT06422767
Study to Evaluate the Effect of Bepirovirsen on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in Healthy Volunteers No drug interventions treatment 1 not_yet_recruiting NCT00059267
Prevention of Recurrent Hepatitis B After Liver Transplantation Not Available Not Available completed NCT01334567
Rollover Protocol Continued Access to Tenofovir Disoproxil Fumarate (TDF) for Subjects in Taiwan treatment 2 completed NCT00753467
A Phase II Study to Determine the Safety and Efficacy of Interferon-gamma in Patients With Chronic Hepatitis B treatment 2 unknown_status NCT00782301
Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected Patients treatment 4 withdrawn NCT03208101
A Study to Compare LBVD to Eupenta and Imovax Polio in Healthy Adults No drug interventions prevention 1 completed NCT04075201
Clinical Trial of Recombinant Hepatitis B Vaccine (Hansenula Polymorpha, 10μg) No drug interventions prevention 1 completed NCT01451801
Cellular Immunity in Adult Hepatitis B-vaccinated Serologic Non-responders prevention 4 unknown_status NCT00188201
Neurocognitive Functioning in Patients With Hepatitis C Pre- and Post-Treatment With Antiviral Medication No drug interventions Not Available Not Available unknown_status NCT00158704
Continued Access Study of Adefovir Dipivoxil (ADV) for Patients w/Chronic HBV Infection. treatment Not Available terminated NCT04778904
First-In-Human Study of ChAdOx1-HBV & MVA-HBV Vaccines (VTP-300) for Chronic HBV treatment 1 / 2 completed NCT04984772
Prospective Cohort of HIV/HBV-coinfected Patients in Europe No drug interventions Not Available Not Available enrolling_by_invitation NCT05442372
Prevalence of HBV in Pregnancy No drug interventions Not Available Not Available recruiting NCT00720668
The Risk of Exacerbation of Chronic Hepatitis B After Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma No drug interventions Not Available Not Available unknown_status NCT00737568
Tenofovir Disoproxil Fumarate (Tenofovir DF) Versus Emtricitabine/Tenofovir DF in Subjects Resistant to Lamivudine treatment 3 completed NCT00138268
Pilot Study Freeze and Transport Immune Cells No drug interventions Not Available Not Available completed NCT00092469
Study of an Investigational Vaccine in Healthy Infants in Taiwan (V441-001)(COMPLETED) prevention 3 completed NCT03897946
Evaluating Immunogenicity of a Birth Dose of HBV Vaccine in the DRC prevention 4 completed NCT01369212
Combination Therapy of Pegylated Interferon Alfa-2a and Tenofovir Versus Tenofovir Monotherapy in Chronic Hepatitis B treatment 3 completed NCT02431312
Phase I Study of INO-1800 With or Without INO-9112 + EP in Chronic Hepatitis B Subjects No drug interventions treatment 1 completed NCT00441012
Study of Modified Process Hib/Hep B Vaccine in Infants (V121-019)(COMPLETED) prevention 3 completed NCT00435812
Safety and Efficacy of HEPLISAV™ Hepatitis B Virus Vaccine Compared With Engerix-B® Vaccine prevention 3 completed NCT00001712
Frequency of Parenteral and Non-Parenteral Exposures to Blood Among Healthcare Workers at the Clinical Center, NIH and at Seven Academic Hospitals in Japan No drug interventions Not Available Not Available completed NCT00498212
A Safety and Efficacy Study of a Single or Double Dose of HEPLISAV™ Hepatitis B Vaccine in Adults With End-Stage Renal Disease prevention 2 terminated NCT00792610
The Hepatitis B Vaccine Booster Response Among the Youth Who Had Completed Neonatal Hepatitis B Vaccines prevention Not Available completed NCT00946010
Investigation of Hepatitis B and Hepatitis C in Taiwan No drug interventions Not Available Not Available completed NCT05541081
Investigating Point-of-care Diagnostics for Sexually Transmitted Infections and Antimicrobial Resistance in Primary Care in Zimbabwe No drug interventions health_services_research Not Available active_not_recruiting NCT01462981
Cohort of Hepatitis B Research of Amsterdam No drug interventions Not Available Not Available unknown_status NCT00335881
Persistence of the Immune Response to Hepatitis B in 4-6 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib prevention 4 completed NCT01050881
Notification of Donors With Positive Microbiology Markers No drug interventions Not Available Not Available completed NCT01444781
Study of the Booster Effect of DTaP-IPV-Hep B-PRP~T Combined Vaccine or Infanrix Hexa™ and Prevenar™ in Healthy Infants prevention 3 completed NCT01018381
Arabinoxylan Rice Bran (MGN-3/Biobran) for the Treatment of Hepatocellular Carcinoma and Hepatitis B and C Infection treatment Not Available completed NCT06160895
A Clinical Trial of TQ-A3334 Tablet After Multiple Administration in Adult Subjects treatment 1 recruiting NCT01777295
Development of Read-outs in Healthy, Hepatitis B Virus Naive Adults Vaccinated With the Hepatitis B Surface Antigen (HBsAg) in Combination With a GlaxoSmithKline (GSK) Biologicals' Adjuvant System prevention 2 completed NCT01457495
Immunogenicity and Safety of DTPa-HBV-IPV/Hib Compared to DTPa-IPV/Hib and HBV Administered Concomitantly prevention 2 completed NCT03341195
Mobile Phone SMS Messages and Automated Calls in Improving Vaccine Coverage Among Children in Pakistan No drug interventions prevention Not Available unknown_status NCT00774995
Immune Response of Healthy Subjects Who Received Neonatal Vaccination Course With Engerix™-B Vaccine. No drug interventions prevention 4 completed NCT03797014
B/F/TAF Switch Study for HIV-HBV Coinfection treatment 4 completed NCT01037114
Long-term Persistence Study in Healthy Adults Previously Vaccinated With Twinrix Adult prevention 4 completed NCT01844414
UCLA-Amity Parolee Health Promotion Study No drug interventions health_services_research Not Available completed NCT00698555
Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 18-40 y No drug interventions prevention 2 completed NCT01924455
HBV-HIV Coinfection Research Network No drug interventions Not Available Not Available completed NCT00412750
Efficacy and Safety of Telbivudine in Treatment naïve Patients With Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB) treatment 3 terminated NCT01513850
A Confirmatory Study of Hepabulin IV in HBsAg Positive Liver Transplantation Recipients No drug interventions prevention 3 completed NCT02985450
A Prospective Study of HBV Immunity and HBV Vaccination in Patients With NAFLD in Canada Not Available Not Available completed NCT04188223
Safety and Immunogenicity Following Recombinant Hepatitis B (Bio Farma) Vaccine in Adults & Children prevention 1 completed NCT05394623
Prevalence and Burden of Hepatitis D Virus Infection in China Through Preoperative Examination Test (Predict Study) No drug interventions Not Available Not Available not_yet_recruiting NCT00393523
Hepatitis B Vaccine Booster Study (V232-058)(COMPLETED) prevention 3 completed NCT02323308
Isolated Anti-HBc Serological Profile in HIV Infected Patients: Immunological, Virological Characteristics and Response to Hepatitis B Vaccination No drug interventions Not Available Not Available completed NCT00051038
Study of Adding Entecavir to Current Lamivudine Therapy in HIV and HBV Co-Infected Patients treatment 2 / 3 completed NCT05102838
Prospective Cohort Study on Prognosis of Patients With Hepatitis B/C No drug interventions Not Available Not Available not_yet_recruiting NCT04998838
Stop Hep B @ Birth prevention Not Available unknown_status NCT01720238
Clinical Effects and Cost-effectiveness Analysis of Early Anti-viral Therapy on HBV-related Compensated Liver Cirrhosis Not Available Not Available unknown_status NCT02644538
Addition of PegIFN Alfa-2a to CHB Patients Treated With Nucleot(s)Ides treatment 4 unknown_status NCT02605538
Hepatitis B in Cystic Fibrosis and Latent Tuberculosis Respectively prevention Not Available withdrawn NCT04499443
Safety, Tolerability and Pharmacokinetic Characteristics Evaluation of GST-HG131 Tablets No drug interventions treatment 1 unknown_status NCT02584543
A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(Coadministration With Recombinant Hepatitis B Vaccine) No drug interventions prevention 4 completed NCT03167229
TDF Medicine to Prevent Mother to Child Transmission of Hepatitis B treatment 4 not_yet_recruiting